Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapy.

Slavina EG; Chertkova AI; Zabotina TN; Ganshina IP; Lichinitser MR

首页> 外文期刊>Bulletin of experimental biology and medicine >Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapy.

【24h】

Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapy.

机译：赫赛汀治疗期间乳腺癌患者中调节性T细胞（CD4 + CD25 +）数量的变化。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

We studied the effect of Herceptin therapy on the population composition of lymphocytes and percentage of CD4+CD25+ cells (regulatory T cells) in breast cancer patients. Herceptin treatment decreased the number of "professional" T suppressors (CD4+CD25+ cells and regulatory T cells) in the peripheral blood.

机译：我们研究了赫赛汀疗法对乳腺癌患者淋巴细胞组成和CD4 + CD25 +细胞（调节性T细胞）百分比的影响。赫赛汀治疗减少了外周血中“专业” T抑制因子（CD4 + CD25 +细胞和调节性T细胞）的数量。

著录项

来源
《Bulletin of experimental biology and medicine 》 |2006年第3期| 共3页
作者
Slavina EG; Chertkova AI; Zabotina TN; Ganshina IP; Lichinitser MR;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类基础医学 ;
关键词
Antibodies; Monoclonal; Antigens; CD4; Antineoplastic Agents; Breast Neoplasms; 抗体; 单克隆; 抗原; CD4; 抗肿瘤药; 乳腺肿瘤; T淋巴细胞;

机译：Antibodies;Monoclonal;Antigens;CD4;Antineoplastic Agents;Breast Neoplasms;抗体;单克隆;抗原;CD4;抗肿瘤药;乳腺肿瘤;T淋巴细胞;

相似文献

外文文献
中文文献
专利

1. Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapy. [J] . Slavina EG, Chertkova AI, Zabotina TN, Bulletin of experimental biology and medicine . 2006 ,第3期

机译：赫赛汀治疗期间乳腺癌患者中调节性T细胞（CD4 + CD25 +）数量的变化。
2. The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN. [J] . Wang YY, He XY, Cai YY, Targeted oncology . 2011 ,第3期

机译：非小细胞肺癌患者外周血和肿瘤微环境中CD4 + CD25 +调节性T细胞的变化及CpG ODN诱导的下调作用。
3. Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2eu peptide (E75) and GM-CSF vaccine. [J] . Hueman MT, Stojadinovic A, Storrer CE, Breast cancer research and treatment. . 2006 ,第1期

机译：乳腺癌患者接种HER2 / neu肽（E75）和GM-CSF疫苗后，循环调节性CD4 + CD25 + T细胞水平降低。
4. Expression of CD4+CD25+ T regulatory cells and Foxp3 in peripheral blood of patients with Rheumatoid Arthritis Patient [C] . Kexin Sun, Yan Li, Suhong Guo, International Conference on Applied Science, Engineering and Technology . 2013

机译：类风湿性关节炎患者外周血CD4 + CD25 + T调节细胞和FOXP3的表达
5. TGF-beta and cancer development: The role of TGF-beta in converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells and a TbetaRIIDN-tk/ganciclovir suicide system in cancer gene therapy [D] . Liu, Victoria Chunyan 2007

机译：TGF-β与癌症的发展：TGF-β在将CD4 + CD25-T细胞转化为CD4 + CD25 + T调节细胞以及TbetaRIIDN-tk /更昔洛韦自杀系统中的作用
6. Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model [O] . H Hong, Y Gu, H Zhang, 2010

机译：CD4 + CD25 +调节性T细胞的耗竭增强了鼠乳腺乳腺癌模型中自然杀伤性T细胞介导的抗肿瘤免疫力
7. CD4+CD25+ Regulatory T-Cell Frequency in HER-2/neu (HER)-Positive and HER-Negative Advanced-Stage Breast Cancer Patients [O] . Sonia A. Perez, Michael V. Karamouzis, Dimosthenes V. Skarlos, 2007

机译：CD4 + CD25 +监管T细胞频率在Her-2 / Neu（她） - 阳性和她的阴性晚期乳腺癌患者

Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapy.

摘要

著录项

相似文献

相关主题

期刊订阅